FDAnews Drug Daily Bulletin
Pharmaceuticals / Research and Development

Takeda Test Drives NICE’s Economic Model Review Service

June 13, 2018

Takeda completed two projects using NICE’s Preliminary Independent Model Advice (PRIMA) service, a fee-based service launched in December 2017 by NICE Scientific Advice to help companies consider the relative clinical and cost effectiveness of their products.

Health economic models are used to demonstrate the value of a product and are an important part of the process for achieving reimbursement and market access.

 “We were delighted to be one of the first companies to work with the PRIMA service, and collaborate with NICE on improving this valuable tool,” said Peter Wheatley-Price, Takeda UK’s market access and pricing director.  

View today's stories